Tramadol Hydrochloride Tablet, Coated
NDC Package 68071-4119-9

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Tramadol Hydrochloride tablets is tramadol HCl tablets are indicated for the management of pain in adults that is severe enough to require an opioid analgesic and for which alternative treatments are inadequate.Limitations of UseBecause of the risks of addiction, abuse, and misuse with opioids, even at recommended doses (see WARNINGS), reserve tramadol HCl tablets for use in patients for whom alternative treatment options [e.g., non-opioid analgesics]: Have not been tolerated, or are not expected to be tolerated.Have not provided adequate analgesia, or are not expected to provide adequate analgesia. . This formulation utilizes a tablet, coated delivery system. Marketed by Nucare Pharmaceuticals,inc., this product is identified by NDC 68071-4119 and is authorized under FDA application ANDA076003.

Identification & Billing

NDC Package Code
68071-4119-9
Package Description
90 TABLET, COATED in 1 BOTTLE
Product Code
68071-4119
11-Digit Billing Format
68071411909
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Tramadol Hydrochloride
Non-Proprietary Name
Tramadol Hydrochloride
Substance Name
Tramadol Hydrochloride
Dosage Form
Tablet, Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is covered with a designated coating.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
TRAMADOL HYDROCHLORIDE 50 mg/1
Pharmacologic Class
Usage Information
Tramadol HCl tablets are indicated for the management of pain in adults that is severe enough to require an opioid analgesic and for which alternative treatments are inadequate.Limitations of UseBecause of the risks of addiction, abuse, and misuse with opioids, even at recommended doses (see WARNINGS), reserve tramadol HCl tablets for use in patients for whom alternative treatment options [e.g., non-opioid analgesics]: Have not been tolerated, or are not expected to be tolerated.Have not provided adequate analgesia, or are not expected to provide adequate analgesia. 
DEA Schedule
Schedule IV (CIV) Substances

Regulatory & Marketing

Labeler Name
Nucare Pharmaceuticals,inc.
Product Type
Human Prescription Drug
FDA Application #
ANDA076003
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
11-15-2010
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (68071-4119). Click a package code to view its specific billing and regulatory data.

68071-4119-1
120 TABLET, COATED in 1 BOTTLE
68071-4119-3
30 TABLET, COATED in 1 BOTTLE
68071-4119-4
40 TABLET, COATED in 1 BOTTLE
68071-4119-5
15 TABLET, COATED in 1 BOTTLE
68071-4119-6
60 TABLET, COATED in 1 BOTTLE
68071-4119-7
84 TABLET, COATED in 1 BOTTLE
68071-4119-8
180 TABLET, COATED in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 68071-4119-9 identifies a specific commercial package of 90 tablet, coated in 1 bottle of Tramadol Hydrochloride, a human prescription drug labeled by Nucare Pharmaceuticals,inc.. This tablet, coated is formulated for oral use and contains tramadol hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Nucare Pharmaceuticals,inc. on November 15, 2010. The current certification is valid through December 31, 2026.

How is this Nucare Pharmaceuticals,inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 68071411909. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
68071-4119-9
11-Digit CMS (5-4-2)
68071-4119-09

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.